Literature DB >> 6690467

Biotyping of Aeromonas isolates as a correlate to delineating a species-associated disease spectrum.

J M Janda, M Reitano, E J Bottone.   

Abstract

A group of 147 Aeromonas isolates from diverse clinical and environmental sources was subjected to the biotyping scheme of Popoff and Veron. Of the 147 isolates biotyped, 137 (93%) could be identified, with Aeromonas hydrophila predominating (48%) and equal percentages (25 to 27%) of the other two species (Aeromonas sobria and Aeromonas caviae). A number of additional biochemical properties were found to be significantly associated with one or more of these three species. These included lysine decarboxylase activity, hemolysis of sheep erythrocytes, lecithinase production, staphylolytic activity, arbutin hydrolysis, and acid production from utilization of various carbohydrates. By incorporating these phenotypic properties into an extended biotyping system, 98% of the isolates were identified. Selective distribution of individual species with respect to certain body sites was noted.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6690467      PMCID: PMC270975          DOI: 10.1128/jcm.19.1.44-47.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Bacteriolytic activity in staphylococci.

Authors:  G Satta; P E Varaldo; G Grazi; R Fontana
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

2.  Clustering of aeromonas hydrophila septicaemia.

Authors:  B D Cookson; E C Houang; J V Lee
Journal:  Lancet       Date:  1981-11-28       Impact factor: 79.321

3.  Freshwater wound infection due to Aeromonas hydrophila.

Authors:  P G Hanson; J Standridge; F Jarrett; D G Maki
Journal:  JAMA       Date:  1977-09-05       Impact factor: 56.272

4.  Taxonomy and description of Vibrio fluvialis sp. nov. (synonym group F vibrios, group EF6).

Authors:  J V Lee; P Shread; A L Furniss; T N Bryant
Journal:  J Appl Bacteriol       Date:  1981-02

5.  Distribution of Aeromonas hydrophila in natural and man-made thermal effluents.

Authors:  T C Hazen; C B Fliermans
Journal:  Appl Environ Microbiol       Date:  1979-07       Impact factor: 4.792

6.  Association of Aeromonas sobria with human infection.

Authors:  O P Daily; S W Joseph; J C Coolbaugh; R I Walker; B R Merrell; D M Rollins; R J Seidler; R R Colwell; C R Lissner
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

Review 7.  Clinical involvement of Aeromonas hydrophila.

Authors:  T J Trust; D C Chipman
Journal:  Can Med Assoc J       Date:  1979-04-21       Impact factor: 8.262

8.  Nosocomial Aeromonas hydrophila cellulitis and bacteremia in a nonimmunocompromised patient.

Authors:  J M Lynch; W R Tilson; G R Hodges; W G Barnes; W J Bopp; I Watanabe
Journal:  South Med J       Date:  1981-07       Impact factor: 0.954

9.  Pseudomonas aeruginosa enzyme profiling: predictor of potential invasiveness and use as an epidemiological tool.

Authors:  J M Janda; E J Bottone
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

10.  Cholera-like illness due to Aeromonas sobria.

Authors:  H Champsaur; A Adremont; D Mathieu; E Rottman; P Auzepy
Journal:  J Infect Dis       Date:  1982-02       Impact factor: 5.226

View more
  55 in total

1.  Electrophoretic analysis of the surface components of autoagglutinating surface array protein-positive and surface array protein-negative Aeromonas hydrophila and Aeromonas sobria.

Authors:  R P Kokka; N A Vedros; J M Janda
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

2.  Aeromonas jandaei (formerly genospecies DNA group 9 A. sobria), a new sucrose-negative species isolated from clinical specimens.

Authors:  A Carnahan; G R Fanning; S W Joseph
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  Identification of Aeromonas strains to the genospecies level in the clinical laboratory.

Authors:  S L Abbott; W K Cheung; S Kroske-Bystrom; T Malekzadeh; J M Janda
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

4.  The type II secretion system is essential for erythrocyte lysis and gut colonization by the leech digestive tract symbiont Aeromonas veronii.

Authors:  Michele Maltz; Joerg Graf
Journal:  Appl Environ Microbiol       Date:  2010-11-19       Impact factor: 4.792

5.  Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems.

Authors:  J S Bakken; C C Sanders; R B Clark; M Hori
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

6.  Cephalothin susceptibility as a potential marker for the Aeromonas sobria group.

Authors:  J M Janda; M R Motyl
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

7.  Further studies on biochemical characteristics and serologic properties of the genus Aeromonas.

Authors:  J M Janda; S L Abbott; S Khashe; G H Kellogg; T Shimada
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

8.  Invasiveness of Aeromonas spp. in relation to biotype, virulence factors, and clinical features.

Authors:  I M Watson; J O Robinson; V Burke; M Gracey
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

9.  Aeromonas caviae: an enteric pathogen?

Authors:  M Altwegg
Journal:  Infection       Date:  1985 Sep-Oct       Impact factor: 3.553

10.  beta-Lactam resistance of motile Aeromonas isolates from clinical and environmental sources.

Authors:  K Morita; N Watanabe; S Kurata; M Kanamori
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.